Chemo is considered the "gold standard" by Vets. I thoroughly agree with you that extended quality of life via MPL should be accepted as the gold standard.
Is it up to PAA to change the mindset among Vets globally?
No, I believe that whichever entity partners with us for Phase 3 and ultimately commercialises MPL will have the task of distribution and marketing of the product in a fashion that will obtain maximum exposure and modification of market sentiment.
PAA's current role is to facilitate the successful outcome of the Phase 2 trial. With our limited marketing budget, I think we are doing whatever is within our resources to encourage trial participants. Of course any publicity is obviously welcome. The more vets that are aware of the MPL trial the better.
The demise of UVet in Werribee has left Victoria unrepresented which is a shame. I assume that Victorian Govt policies are not favorable to conducting the trial in my home state.
We need a few more like Dr Renee across the nation to advocate the trial to prospective patients.
Woof woof! All the best to Bella.
- Forums
- ASX - By Stock
- PAA
- Bella's Monepantel Trial
Bella's Monepantel Trial, page-67
-
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $82.65M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 16.8¢ | $151.1K | 877.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 54714 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 371375 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 54714 | 0.170 |
6 | 317468 | 0.165 |
6 | 179000 | 0.160 |
4 | 512800 | 0.155 |
7 | 295666 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 371375 | 7 |
0.185 | 177426 | 2 |
0.190 | 261458 | 4 |
0.195 | 147632 | 3 |
0.200 | 1055496 | 11 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |